Haemoperfusion should only be used for COVID-19 in the context of randomized trials

Interest in the use of haemoperfusion for severe COVID-19 has been spurred by anecdotal reports of its efficacy and expert reviews suggesting theoretical benefits. However, on the basis of the limited current evidence, haemoperfusion remains an experimental therapy that should only be applied within...

Descripción completa

Detalles Bibliográficos
Autores principales: Clark, Edward G., Hiremath, Swapnil, McIntyre, Lauralyn, Wald, Ron, Hundemer, Gregory L., Joannidis, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478103/
https://www.ncbi.nlm.nih.gov/pubmed/32901129
http://dx.doi.org/10.1038/s41581-020-00352-9
_version_ 1783579997961715712
author Clark, Edward G.
Hiremath, Swapnil
McIntyre, Lauralyn
Wald, Ron
Hundemer, Gregory L.
Joannidis, Michael
author_facet Clark, Edward G.
Hiremath, Swapnil
McIntyre, Lauralyn
Wald, Ron
Hundemer, Gregory L.
Joannidis, Michael
author_sort Clark, Edward G.
collection PubMed
description Interest in the use of haemoperfusion for severe COVID-19 has been spurred by anecdotal reports of its efficacy and expert reviews suggesting theoretical benefits. However, on the basis of the limited current evidence, haemoperfusion remains an experimental therapy that should only be applied within the context of well-designed randomized trials.
format Online
Article
Text
id pubmed-7478103
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-74781032020-09-09 Haemoperfusion should only be used for COVID-19 in the context of randomized trials Clark, Edward G. Hiremath, Swapnil McIntyre, Lauralyn Wald, Ron Hundemer, Gregory L. Joannidis, Michael Nat Rev Nephrol Comment Interest in the use of haemoperfusion for severe COVID-19 has been spurred by anecdotal reports of its efficacy and expert reviews suggesting theoretical benefits. However, on the basis of the limited current evidence, haemoperfusion remains an experimental therapy that should only be applied within the context of well-designed randomized trials. Nature Publishing Group UK 2020-09-08 2020 /pmc/articles/PMC7478103/ /pubmed/32901129 http://dx.doi.org/10.1038/s41581-020-00352-9 Text en © Springer Nature Limited 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Comment
Clark, Edward G.
Hiremath, Swapnil
McIntyre, Lauralyn
Wald, Ron
Hundemer, Gregory L.
Joannidis, Michael
Haemoperfusion should only be used for COVID-19 in the context of randomized trials
title Haemoperfusion should only be used for COVID-19 in the context of randomized trials
title_full Haemoperfusion should only be used for COVID-19 in the context of randomized trials
title_fullStr Haemoperfusion should only be used for COVID-19 in the context of randomized trials
title_full_unstemmed Haemoperfusion should only be used for COVID-19 in the context of randomized trials
title_short Haemoperfusion should only be used for COVID-19 in the context of randomized trials
title_sort haemoperfusion should only be used for covid-19 in the context of randomized trials
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478103/
https://www.ncbi.nlm.nih.gov/pubmed/32901129
http://dx.doi.org/10.1038/s41581-020-00352-9
work_keys_str_mv AT clarkedwardg haemoperfusionshouldonlybeusedforcovid19inthecontextofrandomizedtrials
AT hiremathswapnil haemoperfusionshouldonlybeusedforcovid19inthecontextofrandomizedtrials
AT mcintyrelauralyn haemoperfusionshouldonlybeusedforcovid19inthecontextofrandomizedtrials
AT waldron haemoperfusionshouldonlybeusedforcovid19inthecontextofrandomizedtrials
AT hundemergregoryl haemoperfusionshouldonlybeusedforcovid19inthecontextofrandomizedtrials
AT joannidismichael haemoperfusionshouldonlybeusedforcovid19inthecontextofrandomizedtrials

Ejemplares similares